Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals

Alzheimer’s disease biomarkers are primarily evaluated through MRI, PET and CSF methods in order to diagnose and monitor disease. Recently, advances in the assessment of blood-based biomarkers have shown promise for simple, inexpensive, accessible and minimally invasive tools with diagnostic and pro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Brain Commun
Autori principali: Lussier, Firoza Z, Benedet, Andréa L, Therriault, Joseph, Pascoal, Tharick A, Tissot, Cécile, Chamoun, Mira, Mathotaarachchi, Sulantha, Savard, Melissa, Ashton, Nicholas J, Karikari, Thomas K, Rodriguez, Juan Lantero, Snellman, Anniina, Bezgin, Gleb, Kang, Min Su, Fernandez Arias, Jaime, Wang, Yi-Ting, Gauthier, Serge, Zetterberg, Henrik, Blennow, Kaj, Rosa-Neto, Pedro
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2021
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088291/
https://ncbi.nlm.nih.gov/pubmed/33959711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/braincomms/fcab073
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi